mRNA Vaccines to Prevent COVID-19 Disease and Reported Allergic Reactions: Current Evidence and Suggested Approach

The U.S. Food and Drug Administration (FDA) has recently issued an Emergency Use Authorization (EUA) for 2 highly effective coronavirus disease 2019 (COVID-19) vaccines from Pfizer-BioNTech and Moderna. This has brought hope to millions of Americans in the midst of an ongoing global pandemic. The FD...

詳細記述

保存先:
書誌詳細
出版年:J Allergy Clin Immunol Pract
主要な著者: Banerji, Aleena, Wickner, Paige G., Saff, Rebecca, Stone, Cosby A., Robinson, Lacey B., Long, Aidan A., Wolfson, Anna R., Williams, Paul, Khan, David A., Phillips, Elizabeth, Blumenthal, Kimberly G.
フォーマット: Artigo
言語:Inglês
出版事項: American Academy of Allergy, Asthma & Immunology 2021
主題:
Review and Feature Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC7948517/
https://ncbi.nlm.nih.gov/pubmed/33388478
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jaip.2020.12.047
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料